TNFRSF9 and cancer: Although CD137 signaling network in Texint of other cancer types was not detected unlike the patients with LUAD, it was highly conservative in various cancer types that 1CM was upregulated in proliferative Texint, which were enriched in ICB-treatment non-responders.